BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34589886)

  • 1. The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases.
    Mayfield RD; Zhu L; Smith TA; Tiwari GR; Tucker HO
    Brain Behav Immun Health; 2020 Dec; 9():100129. PubMed ID: 34589886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. skNAC and Smyd1 in transcriptional control.
    Berkholz J; Orgeur M; Stricker S; Munz B
    Exp Cell Res; 2015 Aug; 336(2):182-91. PubMed ID: 26162853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation.
    Zhu L; Brown MA; Sims RJ; Tiwari GR; Nie H; Mayfield RD; Tucker HO
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-mediated inhibition of skNAC and Smyd1 expression disrupts myofibril organization: Immunofluorescence and electron microscopy study in C2C12 cells.
    Berkholz J; Eberle R; Boller K; Munz B
    Micron; 2018 May; 108():6-10. PubMed ID: 29499397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 SUMO ligase Nse2 regulates sumoylation and nuclear-to-cytoplasmic translocation of skNAC-Smyd1 in myogenesis.
    Berkholz J; Michalick L; Munz B
    J Cell Sci; 2014 Sep; 127(Pt 17):3794-804. PubMed ID: 25002400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.
    Park CY; Pierce SA; von Drehle M; Ivey KN; Morgan JA; Blau HM; Srivastava D
    Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20750-5. PubMed ID: 21071677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor.
    Yotov WV; St-Arnaud R
    Genes Dev; 1996 Jul; 10(14):1763-72. PubMed ID: 8698236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smyd1 facilitates heart development by antagonizing oxidative and ER stress responses.
    Rasmussen TL; Ma Y; Park CY; Harriss J; Pierce SA; Dekker JD; Valenzuela N; Srivastava D; Schwartz RJ; Stewart MD; Tucker HO
    PLoS One; 2015; 10(3):e0121765. PubMed ID: 25803368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smyd1: Implications for novel approaches in rhabdomyosarcoma therapy.
    Berkholz J; Schmitt A; Fragasso A; Schmid AC; Munz B
    Exp Cell Res; 2024 Jan; 434(2):113863. PubMed ID: 38097153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated Smyd1 participated in the inhibition of myoblast differentiation induced by cigarette smoke extract.
    Li F; Xu M; Miao J; Hu N; Wang Y; Wang L
    Toxicol Lett; 2023 Jul; 383():98-111. PubMed ID: 37385529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. skNAC (skeletal Naca), a muscle-specific isoform of Naca (nascent polypeptide-associated complex alpha), is required for myofibril organization.
    Li H; Randall WR; Du SJ
    FASEB J; 2009 Jun; 23(6):1988-2000. PubMed ID: 19211926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. skNAC depletion stimulates myoblast migration and perturbs sarcomerogenesis by enhancing calpain 1 and 3 activity.
    Berkholz J; Zakrzewicz A; Munz B
    Biochem J; 2013 Jul; 453(2):303-10. PubMed ID: 23662692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.
    Berkholz J; Kuzyniak W; Hoepfner M; Munz B
    Clin Exp Metastasis; 2014 Dec; 31(8):869-79. PubMed ID: 25209525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of novel injury-regulated genes. Implications for an important role of the muscle-specific protein skNAC in muscle repair.
    Munz B; Wiedmann M; Lochmüller H; Werner S
    J Biol Chem; 1999 May; 274(19):13305-10. PubMed ID: 10224091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.
    Li D; Niu Z; Yu W; Qian Y; Wang Q; Li Q; Yi Z; Luo J; Wu X; Wang Y; Schwartz RJ; Liu M
    Nucleic Acids Res; 2009 Nov; 37(21):7059-71. PubMed ID: 19783823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1.
    Nagandla H; Lopez S; Yu W; Rasmussen TL; Tucker HO; Schwartz RJ; Stewart MD
    Dev Biol; 2016 Feb; 410(1):86-97. PubMed ID: 26688546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle-specific variant of nascent polypeptide associated complex alpha (skNAC): implications for a specific role in mammalian myoblast differentiation.
    Berger F; Berkholz J; Breustedt T; Ploen D; Munz B
    Eur J Cell Biol; 2012 Feb; 91(2):150-5. PubMed ID: 22154550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
    Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
    Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-specific expression of the smyd1 gene is controlled by its 5.3-kb promoter and 5'-flanking sequence in zebrafish embryos.
    Du SJ; Rotllant J; Tan X
    Dev Dyn; 2006 Dec; 235(12):3306-15. PubMed ID: 17048253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.